Point72 Hong Kong’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-204
Closed -$37K 2221
2021
Q1
$37K Sell
204
-210
-51% -$41.8K ﹤0.01% 1343
2020
Q4
$46K Sell
414
-535
-56% -$56.9K ﹤0.01% 1248
2020
Q3
$103K Sell
949
-180
-16% -$21.9K 0.01% 552
2020
Q2
$94K Buy
+1,129
New +$43.2K 0.01% 641
2019
Q2
Sell
-1,029
Closed -$11K 1321
2019
Q1
$11K Buy
+1,029
New +$32.5K ﹤0.01% 753
2018
Q2
Sell
-825
Closed -$35K 1103
2018
Q1
$35K Buy
+825
New +$33.1K 0.02% 533
2016
Q4
Sell
-740
Closed -$31K 989
2016
Q3
$31K Buy
+740
New +$95.5K 0.02% 529

Other funds holding NVAX

Point72 Hong Kong's NVAX Position: Q2 2021 in Review

Point72 Hong Kong sold out of Novavax (NVAX) in Q2 2021, closing a stake of 204 shares — an estimated $37K sold.

Point72 Hong Kong first reported a position in NVAX in Q3 2016 and held it in 7 quarters. The position peaked at $103K in Q3 2020. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • Point72 Hong Kong reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 204 Novavax shares in Q2 2021, an estimated $37K.
  • Point72 Hong Kong first reported a position in Novavax in Q3 2016 and held it in 7 quarters.
  • Point72 Hong Kong's Novavax position peaked at $103K in Q3 2020.
  • 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.